LabCorp to Offer Risk Stratification Tool for Ovarian Mass Malignancy

摘要

LabCorp in January announced the nationwide availability of a new Food and Drug Administration-cleared risk stratification tool for determining whether an ovarian mass is at high or low likelihood of being malignant.